A growing hedge fund based in New York City with over $1bn AUM is looking to bring on a Long/Short Equity Biotech research analyst. In this role you will work closely with the CIO to identify and analyze investment opportunities in the biotech/ therapeutics sector. The ideal candidate will have a PhD or MD and have several years of buy-side research experience with a deeply fundamental approach to investing. A medical background is not required but it is preferred.
- Strong academic track record, technical or life science degree is preferred
- At least 3 years of buyside biotech analyst experience preferred
- Strong financial modeling skills and a passion for investing, learning, solving complex research questions
Please apply if you meet the qualifications!